Medicaid

Charlie Baker

Biotech

MassBio’s push to soften state drug-price legislation produces plenty of drama

By Jon Chesto — Boston Globe

Pharmalot

Pharmalittle: Medicare proposes boosting payments for CAR-T drugs; Sacklers want to settle opioid suits

By Ed Silverman

advertisement

Chuck Grassley, Ron Wyden

Pharmalot

Lawmakers ask the Trump administration to investigate PBM pricing practices

By Ed Silverman

advertisement

Federal Building DOJ

Pharmalot

Indivior charged with conducting multibillion-dollar fraud to boost opioid-treatment sales

By Ed Silverman

Home caregiver

First Opinion

Health aides’ low wages threaten home health care, a necessity for millions

By David Totaro

Crushed Aluminum Can on side of road

First Opinion

Sen. Grassley: Stop kicking Medicaid’s safety net hospital payments down the road

By Chuck Grassley

Amarin Transcript

Hospitals

CMS proposes changing requirements for less-invasive heart valve procedure

By Matthew Herper

advertisement

Pharmalot

Kentucky probes pharmacy benefit managers for allegedly overcharging state Medicaid

By Ed Silverman

advertisement

Optum

Pharmalot

Amid probe into PBMs, Ohio sues OptumRx for $16 million, and the AG says ‘there’s a storm a-comin’’

By Ed Silverman

Chemotherapy infusion

Pharmalot

Patient advocacy groups in Canada with ties to pharma are big boosters for government coverage

By Ed Silverman

Pharmalot

Pharmalittle: Lilly to sell version of insulin at half price; senators push drug price gouging bill

By Ed Silverman

Optum

Pharmalot

Ohio seeks $16m from UnitedHealth’s PBM for overcharging on drugs

By Ed Silverman

Optum

Pharmalot

A big PBM wants drug makers to agree to rebate demands that would preserve its bottom line

By Ed Silverman and Ike Swetlitz

Cloud of obscurity

First Opinion

‘Cloud of secrecy’ in Medicare Advantage plans can create an environment for fraud

By Jeanne A. Markey and Raymond M. Sarola

Hep C San Fran

Pharmalot

Washington state becomes the latest to embrace a Netflix model for buying hep C drugs

By Ed Silverman

Pharmalot

Pharmalittle: Senate committee ‘reinvites’ big drug makers to testify; can pharma use AI to solidify patents?

By Ed Silverman

Priceberg

First Opinion

We’re missing the true point of hospital price transparency

By Jay Deady

Marylou Sudders

Pharmalot

Here’s how Massachusetts officials hope to lower their Medicaid drug spending

By Ed Silverman

Pharmalot

Pharmalittle: Massachusetts seeks to negotiate directly with pharma; Civica looks to make 20 generics

By Ed Silverman

Pharmacy shelves

Pharmalot

Pharmacy benefit managers marked up generic drugs for NY Medicaid, but where’d the money go?

By Ed Silverman

WALGREENS

Pharmalot

Walgreens pays $269 million to settle charges of overbilling government health programs

By Ed Silverman

Pharmalot

Pharmalittle: AstraZeneca chief medical officer is leaving; a venture capital firm bids farewell to J.P. Morgan

By Ed Silverman

Pharmalot

Pharmalittle: Drug prices may rise up to 9 percent next month; Novartis seeks to boost CAR-T manufacturing

By Ed Silverman

Senators Opioid Report

Pharmalot

Wyden probes ties between opioid makers, advocacy groups, and a government panel

By Ed Silverman

Pharmalot

Feds want to dismiss lawsuits alleging nurse educator programs are kickback schemes

By Ed Silverman

Pharmalot

Pharmalittle: House moves bill to thwart Medicaid misclassifications; McDonald’s to cut antibiotic use in beef

By Ed Silverman

CVS Miami

Pharmalot

Pennsylvania auditor recommends new laws to crack down on PBM contracts for Medicaid

By Ed Silverman

Pharmalot

Pharmalittle: Takeda shareholders approve Shire deal; HPV vaccine program in Quebec divides experts

By Ed Silverman

Pharmalot

Justice Department tells Supreme Court it wants to scuttle a whistleblower case against Gilead

By Ed Silverman